Symrise Offloads U.S. Terpene Unit to Mutares in Portfolio Shift

AmeriTerpenes, which operates production facilities across Florida and Georgia, produces the biomolecules essential for scent and flavor applications. Symrise leadership stated that the move follows a months-long operational carve-out designed to prepare the unit for independent development. Chief Executive Jean-Yves Parisot framed the transaction as a strategic effort to sharpen the firm’s competitive profile.

While the specific purchase price remains confidential, the financial impact of the sale will appear in the company’s 2026 books. The resulting impairment reflects the adjustment of the asset's value as it transitions under the control of Mutares. Existing commercial agreements ensure that Symrise retains access to the terpene-based raw materials produced by the divested business, maintaining continuity for its food and cosmetics clients.